Company: SRPT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001193125-25-269436
Chunk: 0

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
SAREPTA THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited, in thousands, except share and per share amounts)

     As of September 30, 2025

     As of December 31, 2024

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     613,077

     $
     1,103,010

     Short-term investments

     237,916

     251,782

     Accounts receivable, net

     395,739

     601,988

     Inventory

     1,077,166

     749,960

     Manufacturing-related deposits and prepaids

     206,062

     276,262

     Other current assets

     192,349

     90,461

     Total current assets

     2,722,309

     3,073,463

     Property and equipment, net

     358,936

     340,336

     Right of use assets

     139,167

     148,310

     Non-current inventory

     198,601

     187,986

     Non-current investments

     1,040

     133,163

     Other non-current assets

     73,384

     79,915

     Total assets
      
     $
     3,493,437

     $
     3,963,173

     Liabilities and Stockholders’ Equity

     Current liabilities:

     Accounts payable
      
     $
     94,015

     $
     214,442

     Accrued expenses

     295,793

     373,513

     Deferred revenue, current portion

     485,449

     130,256

     Contingent consideration, current portion

     36,000

     —

     Other current liabilities

     10,168

     13,473

     Total current liabilities

     921,425

     731,684

     Long-term debt

     1,035,146

     1,137,124

     Lease liabilities, net of current portion

     215,042

     192,473

     Deferred revenue, net of current portion

     —

     325,000

     Contingent consideration, net of current portion